These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26061601)

  • 1. Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease.
    Sundaram GS; Dhavale D; Prior JL; Sivapackiam J; Laforest R; Kotzbauer P; Sharma V
    EJNMMI Res; 2015 Dec; 5(1):112. PubMed ID: 26061601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.
    Sundaram GS; Dhavale DD; Prior JL; Yan P; Cirrito J; Rath NP; Laforest R; Cairns NJ; Lee JM; Kotzbauer PT; Sharma V
    Sci Rep; 2016 Nov; 6():35636. PubMed ID: 27805057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and preliminary evaluation of [
    He Y; Zhu X; Wang K; Xie J; Zhu Z; Ni M; Wang S; Xie Q
    Bioorg Med Chem; 2022 Dec; 75():117087. PubMed ID: 36356533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical study on [
    Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice.
    Yousefi BH; von Reutern B; Scherübl D; Manook A; Schwaiger M; Grimmer T; Henriksen G; Förster S; Drzezga A; Wester HJ
    EJNMMI Res; 2015; 5():20. PubMed ID: 25918674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
    Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
    J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
    Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
    J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
    Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B
    Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β-amyloid plaques by positron emission tomography.
    Yang Y; Fu H; Cui M; Peng C; Liang Z; Dai J; Zhang Z; Lin C; Liu B
    Eur J Med Chem; 2015 Nov; 104():86-96. PubMed ID: 26435514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G
    J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
    Zhang W; Kung MP; Oya S; Hou C; Kung HF
    Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and preclinical study of a novel
    Jokar S; Behnammanesh H; Erfani M; Sharifzadeh M; Gholami M; Sabzevari O; Amini M; Geramifar P; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jun; 99():103857. PubMed ID: 32330736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.